These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9613624)

  • 1. Integrating schizophrenia.
    Gray JA
    Schizophr Bull; 1998; 24(2):249-66. PubMed ID: 9613624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.
    O'Donnell P; Grace AA
    Schizophr Bull; 1998; 24(2):267-83. PubMed ID: 9613625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
    Swerdlow NR; Geyer MA
    Schizophr Bull; 1998; 24(2):285-301. PubMed ID: 9613626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia.
    Gray JA; Joseph MH; Hemsley DR; Young AM; Warburton EC; Boulenguez P; Grigoryan GA; Peters SL; Rawlins JN; Taib CT
    Behav Brain Res; 1995 Nov; 71(1-2):19-31. PubMed ID: 8747172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia.
    Gray JA
    Neuropsychologia; 1995 Sep; 33(9):1143-53. PubMed ID: 7501135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dreaming and schizophrenia: a common neurobiological background?].
    Gottesmann C
    Med Sci (Paris); 2006 Feb; 22(2):201-5. PubMed ID: 16457764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical brain dysfunction in early schizophrenia: secondary pathogenetic hierarchy of neuroplasticity, psychopathology and social impairment.
    Hemmingsen R; Madsen A; Glenthøj B; Rubin P
    Acta Psychiatr Scand Suppl; 1999; 395():80-8. PubMed ID: 10225336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia.
    Csernansky JG; Bardgett ME
    Schizophr Bull; 1998; 24(2):231-48. PubMed ID: 9613623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia.
    Feldon J; Weiner I
    J Psychiatr Res; 1992 Oct; 26(4):345-66. PubMed ID: 1491358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent inhibition-related dopaminergic responses in the nucleus accumbens are disrupted following neonatal transient inactivation of the ventral subiculum.
    Meyer FF; Louilot A
    Neuropsychopharmacology; 2011 Jun; 36(7):1421-32. PubMed ID: 21430650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction, perception, and psychosis: Application of associative learning theories to schizophrenia research.
    Suzuki R; Kosaki Y
    Behav Neurosci; 2024 Jun; 138(3):195-211. PubMed ID: 38934921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Startle habituation and sensorimotor gating in schizophrenia and related animal models.
    Geyer MA; Braff DL
    Schizophr Bull; 1987; 13(4):643-68. PubMed ID: 3438708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia.
    Mikell CB; McKhann GM; Segal S; McGovern RA; Wallenstein MB; Moore H
    Stereotact Funct Neurosurg; 2009; 87(4):256-65. PubMed ID: 19556835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
    Weiner I
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region, but this lesion effect can be prevented by systemic haloperidol treatment.
    Yee BK; Feldon J; Rawlins JN
    Behav Neurosci; 1995 Apr; 109(2):227-40. PubMed ID: 7619313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cycloid type and its differentiation from core schizophrenia: a phenomenological approach.
    Sigmund D; Mundt C
    Compr Psychiatry; 1999; 40(1):4-18. PubMed ID: 9924871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
    Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH
    J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conditioned reflex dopamine release in the nucleus accumbens in rats with disrupted hippocampal formation].
    Saul'skaia NB; Gorbachevskaia AI
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(1-2):76-82. PubMed ID: 13676988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic responses in the core part of the nucleus accumbens to subcutaneous MK801 administration are increased following postnatal transient blockade of the prefrontal cortex.
    Tagliabue E; Pouvreau T; Eybrard S; Meyer F; Louilot A
    Behav Brain Res; 2017 Sep; 335():191-198. PubMed ID: 28823626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perplexing effects of hippocampal lesions on latent inhibition: a neural network solution.
    Buhusi CV; Gray JA; Schmajuk NA
    Behav Neurosci; 1998 Apr; 112(2):316-51. PubMed ID: 9588481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.